PROTEINS HUMAN CONSUMPTION

Brand Owner (click to sort) Address Description
EMSER Campina Melkunie B.V. Hogeweg 9 5301 LB ZALTBOMMEL Netherlands proteins for human consumption for use as a food additive or filler;
EMSER FRIESLANDCAMPINA NEDERLAND B.V. Stationsplein 4 AMERSFOORT 3818LE Netherlands Proteins for human consumption for use as food additive or filler;
REGENERADE DSM IP ASSETS B.V. Het Overloon 1 Heerlen 6411TE Netherlands Proteins for human consumption;REGENERATE ADE;Chemical and biochemical products for use in the food industry and in the pharmaceutical industry; chemical and biochemical substances for preserving foodstuffs;Mineral and aerated waters and other non-alcoholic drinks; fruit drinks and fruit juices; syrups and other preparations for making beverages;
ULTRAPEP KERRY GROUP SERVICES INTERNATIONAL LIMITED Prince's Street, Tralee Co. Kerry Ireland [ Proteins for human consumption ];Preparations of micro-organisms for veterinary or medical use; nutritive substances for micro-organisms; media for cultures of microorganisms; proteins, proteins for cell nutrition, hydrolised proteins and hydrolysates, all for pharmaceutical, medical or veterinary purposes; culture media, namely, tissue culture media for medical or veterinary use;ULTRA PEP;Color is not claimed as a feature of the mark.;Cultures of micro-organisms; bacteriological cultures; chemicals used in industry and science; proteins, proteins for cell nutrition, hydrolised proteins, hydrolysates, cell cultures and protein based cultures, all for use as a raw material in the manufacture of other goods; enzymatic digest of protein; Chemicals for use in science and industry, namely, tissue culture media preparations;[ Proteins for animal consumption ];
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. A process for selecting human cells for the production of human proteins by endogenous gene activation allows human proteins to be produced in economically feasible quantities and in a form suitable for producing a pharmaceutical composition. Also disclosed is a process for producing human proteins in a cell line identified in this matter.